Search
Now showing items 1-3 of 3
HSP20 inhibits amyloidogenesis and neurotoxicity
(United States. Patent and Trademark Office, 2014-04-29)
The present invention compositions and methods of using at least a portions of an isolated and purified α-crystallin polypeptide that includes one or more β-pleated sheets and that prevents neurotoxicity and amyloidogenesis.
HSP20 inhibits amyloidogenesis and neurotoxicity
(United States. Patent and Trademark Office, 2016-04-26)
The present invention compositions and methods of using at least a portions of an isolated and purified α-crystallin polypeptide that includes one or more β-pleated sheets and that prevents neurotoxicity and amyloidogenesis.
HSP20 inhibits amyloidogenesis and neurotoxicity
(United States. Patent and Trademark Office, 2017-10-31)
The present invention compositions and methods of using at least a portions of an isolated and purified α-crystallin polypeptide that includes one or more β-pleated sheets and that prevents neurotoxicity and amyloidogenesis.